Works matching IS 19466234 AND DT 2024 AND VI 16 AND IP 741

Results: 5

Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates.
Published in:
Science Translational Medicine, 2024, v. 16, n. 741, p. 1, doi. 10.1126/scitranslmed.adl2055
By:
- Zeitlin, Larry;
- Cross, Robert W.;
- Woolsey, Courtney;
- West, Brandyn R.;
- Borisevich, Viktoriya;
- Agans, Krystle N.;
- Prasad, Abhishek N.;
- Deer, Daniel J.;
- Stuart, Lauren;
- McCavitt-Malvido, Maria;
- Kim, Do H.;
- Pettitt, James;
- Crowe Jr., James E.;
- Whaley, Kevin J.;
- Veesler, David;
- Dimitrov, Antony;
- Abelson, Dafna M.;
- Geisbert, Thomas W.;
- Broder, Christopher C.
Publication type:
Article
Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model.
Published in:
Science Translational Medicine, 2024, v. 16, n. 741, p. 1, doi. 10.1126/scitranslmed.adj9052
By:
- Hou, Jinchao;
- Chen, Yun;
- Cai, Zhangying;
- Heo, Gyu Seong;
- Yuede, Carla M.;
- Wang, Zuoxu;
- Lin, Kent;
- Saadi, Fareeha;
- Trsan, Tihana;
- Nguyen, Aivi T.;
- Constantopoulos, Eleni;
- Larsen, Rachel A.;
- Zhu, Yiyang;
- Wagner, Nicole D.;
- McLaughlin, Nolan;
- Kuang, Xinyi Cynthia;
- Barrow, Alexander D.;
- Li, Dian;
- Zhou, Yingyue;
- Wang, Shoutang
Publication type:
Article
TSPAN8<sup>+</sup> myofibroblastic cancer–associated fibroblasts promote chemoresistance in patients with breast cancer.
Published in:
Science Translational Medicine, 2024, v. 16, n. 741, p. 1, doi. 10.1126/scitranslmed.adj5705
By:
- Fan, Guangjian;
- Yu, Bo;
- Tang, Lei;
- Zhu, Rongxuan;
- Chen, Jianhua;
- Zhu, Ying;
- Huang, He;
- Zhou, Liying;
- Liu, Jun;
- Wang, Wei;
- Tao, Zhonghua;
- Zhang, Fengchun;
- Yu, Siwei;
- Lu, Xiaoqing;
- Cao, Yuan;
- Du, Shaoqian;
- Li, Huihui;
- Li, Junjian;
- Zhang, Jian;
- Ren, He
Publication type:
Article
Pathogenic TNNI1 variants disrupt sarcomere contractility resulting in hypo- and hypercontractile muscle disease.
Published in:
Science Translational Medicine, 2024, v. 16, n. 741, p. 1, doi. 10.1126/scitranslmed.adg2841
By:
- Donkervoort, Sandra;
- van de Locht, Martijn;
- Ronchi, Dario;
- Reunert, Janine;
- McLean, Catriona A.;
- Zaki, Maha;
- Orbach, Rotem;
- de Winter, Josine M.;
- Conijn, Stefan;
- Hoomoedt, Daan;
- Neto, Osorio Lopes Abath;
- Magri, Francesca;
- Viaene, Angela N.;
- Foley, A. Reghan;
- Gorokhova, Svetlana;
- Bolduc, Véronique;
- Hu, Ying;
- Acquaye, Nicole;
- Napoli, Laura;
- Park, Julien H.
Publication type:
Article
Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease.
Published in:
Science Translational Medicine, 2024, v. 16, n. 741, p. 1, doi. 10.1126/scitranslmed.adj0133
By:
- Pan, Ziyan;
- El Sharkway, Rasha;
- Bayoumi, Ali;
- Metwally, Mayada;
- Gloss, Brian S.;
- Brink, Robert;
- Lu, David Bo;
- Liddle, Christopher;
- Alqahtani, Saleh A.;
- Yu, Jun;
- O'Connell, Philip J.;
- George, Jacob;
- Eslam, Mohammed
Publication type:
Article

Works matching IS 19466234 AND DT 2024 AND VI 16 AND IP 741

Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates.

Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model.

TSPAN8<sup>+</sup> myofibroblastic cancer–associated fibroblasts promote chemoresistance in patients with breast cancer.

Pathogenic TNNI1 variants disrupt sarcomere contractility resulting in hypo- and hypercontractile muscle disease.

Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease.